
Concentric Health
The market leading digital consent (econsent) to treatment application.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 Valuation: €0.0 | round | |
* | £400k | Grant | |
Total Funding | 000k |
USD | 2019 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | 11 % | 110 % |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
% profit margin | (13 %) | - | - | - |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Concentric Health, a health technology company based in Cardiff, UK, was founded in 2019 by Dafydd Loughran, Edward St John, and Martyn Loughran. The company was established to transform the process of consent to treatment into a more patient-centric, informed, and collaborative experience.
Dafydd Loughran, a co-founder and the current CEO, has a background as a surgeon. This experience in a clinical setting provided him with firsthand insight into the limitations of traditional consent processes, which heavily influenced the development of Concentric Health's core product.
The company's main offering is a digital consent and shared decision-making application. This platform digitizes the entire consent process, moving away from paper-based forms and toward an interactive, digital experience. The application provides patients with personalized information about their treatment options, including the potential benefits and risks associated with each. This allows patients to make more informed decisions about their care in collaboration with their clinicians.
The business model is centered on providing this software to healthcare organizations, such as hospitals and clinics. By streamlining the consent process, the platform aims to improve efficiency for healthcare providers while enhancing the patient experience. The company has received backing from investors, including a £500,000 investment from a syndicate of 24 business angels, to support its growth and the expansion of its platform.
Keywords: eConsent, shared decision-making, health technology, patient-centric care, digital health, medical software, clinical workflow, patient engagement, healthcare administration, surgical consent